Review of the Drug Enforcement Administration's Regulatory and Enforcement Efforts to Control the Diversion of Opioids
- NARA ID
- review-drug-enforcement-administrations-regulatory-and-enforcement-efforts-control
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2019-10-01
- Slug
- doj-oig-review-drug-enforcement-administrations-regulatory-and-enforcement-efforts-control
- Indexed
- 2026-04-27 05:04:21
More from DOJ OIG — Drug Enforcement Administration
- A Review of the Drug Enforcement Administration's Use of Administrative Subpoenas to Collect or Exploit Bulk Data (Revised March 2025)
- Memorandum for the Deputy Attorney General: Recommendation for the Drug Enforcement Administration to Review whether its Field Offices are Engaging in Unlawful Fundraising on Behalf of the Drug Enforcement Administration Survivors Benefit Fund
- Audit of the Drug Enforcement Administration's Confidential Source Policies and Oversight of Higher-Risk Confidential Sources
- Investigative Summary: Findings of Misconduct by a then Senior Official with the Drug Enforcement Administration for Misuse of Official Position Related to Giving Preferential Treatment to a Pharmaceutical Company, and Related Misconduct
- Report of Investigation of the Actions of Former DEA Leadership in Connection with the Reinstatement of a Security Clearance
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration Assistant Special Agent in Charge for Violating the Anti-Nepotism Statute and DEA Personal Conflict of Interest Policy
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.